Jane Lowe Meisel
Dr. Jane Lowe Meisel is a prominent oncologist and co-director of breast medical oncology at the Winship Cancer Institute of Emory University. She is recognized for her expertise in breast cancer treatment and has contributed significantly to clinical research, particularly in targeted therapies for hormone receptor-positive breast cancer. Her insights during the American Society of Clinical Oncology (ASCO) annual meeting highlighted the potential of a new triple therapy that improves survival rates for patients with PIK3CA-mutated breast cancer.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 9.00 | 0.04% | +0% | 67,886,011 | 28,286 | $2,700,000 | 1,125$ |
| Totals | 1 | 67,886,011 | 28,286 | $2,700,000 | 1,125$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Dr Jane Lowe Meisel is the co-director of breast medical oncology at Winship Cancer Institute of Emory University and an Asco expert in breast cancer.
9